TipRanks
Advertisement
Advertisement

CPHRF Stock Latest News

Cipher Pharmaceuticals Strengthens Board with Appointment of Industry Veteran Rajiv De Silva
Company AnnouncementsCipher Pharmaceuticals Strengthens Board with Appointment of Industry Veteran Rajiv De Silva
2d ago
Cipher Wins U.S. Court Ruling Upholding Absorica LD Arbitration Award Against Sun Pharma
PremiumCompany Announcements
Cipher Wins U.S. Court Ruling Upholding Absorica LD Arbitration Award Against Sun Pharma
22d ago
Cipher Pharmaceuticals Balances U.S. Strain With Epuris Strength
PremiumCompany Announcements
Cipher Pharmaceuticals Balances U.S. Strain With Epuris Strength
1M ago
Cipher Pharmaceuticals price target lowered to C$20 from C$22 at Stifel
PremiumThe Fly
Cipher Pharmaceuticals price target lowered to C$20 from C$22 at Stifel
1M ago
Cipher Pharmaceuticals Balances Q2 Earnings Dip With Epuris Growth and Strong Balance Sheet
PremiumCompany Announcements
Cipher Pharmaceuticals Balances Q2 Earnings Dip With Epuris Growth and Strong Balance Sheet
1M ago
Is CPHRF a Buy, Before Earnings?
PremiumPre-EarningsIs CPHRF a Buy, Before Earnings?
2M ago
Cipher Pharmaceuticals price target raised to C$22 from C$21 at Stifel
Premium
The Fly
Cipher Pharmaceuticals price target raised to C$22 from C$21 at Stifel
4M ago
CaryHealth launches direct-to-patient program for Cipher’s Natroba
Premium
The Fly
CaryHealth launches direct-to-patient program for Cipher’s Natroba
6M ago
Cipher Pharmaceuticals price target raised to C$21 from C$20 at Stifel
PremiumThe Fly
Cipher Pharmaceuticals price target raised to C$21 from C$20 at Stifel
6M ago
Cipher Pharmaceuticals Delivers Record 2025 Results and Primes for Next Acquisition Phase
PremiumCompany Announcements
Cipher Pharmaceuticals Delivers Record 2025 Results and Primes for Next Acquisition Phase
7M ago
Is CPHRF a Buy, Before Earnings?
PremiumPre-Earnings
Is CPHRF a Buy, Before Earnings?
7M ago
Cipher Pharmaceuticals Sets March Date for Q4 and Fiscal 2025 Results
PremiumCompany Announcements
Cipher Pharmaceuticals Sets March Date for Q4 and Fiscal 2025 Results
7M ago
Cipher Wins Health Canada Review for Natroba Head Lice and Scabies Treatment
PremiumCompany AnnouncementsCipher Wins Health Canada Review for Natroba Head Lice and Scabies Treatment
8M ago
Cipher Pharmaceuticals: Strong Q3 2025 Earnings Call
Premium
Company Announcements
Cipher Pharmaceuticals: Strong Q3 2025 Earnings Call
11M ago
Cipher Pharmaceuticals Reports Strong Q3 2025 Results
Premium
Company Announcements
Cipher Pharmaceuticals Reports Strong Q3 2025 Results
11M ago
Cipher Pharmaceuticals Reports Strong Q3 2025 Financial Results
PremiumCompany Announcements
Cipher Pharmaceuticals Reports Strong Q3 2025 Financial Results
11M ago
Cipher Pharmaceuticals Achieves Strong Q3 2025 Financial Performance
PremiumCompany Announcements
Cipher Pharmaceuticals Achieves Strong Q3 2025 Financial Performance
11M ago
Cipher Pharmaceuticals Inc (CPHRF) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Cipher Pharmaceuticals Inc (CPHRF) Q3 Earnings Cheat Sheet
11M ago
Cipher Pharmaceuticals to Announce Q3 2025 Financial Results
PremiumCompany Announcements
Cipher Pharmaceuticals to Announce Q3 2025 Financial Results
11M ago
Cipher Pharmaceuticals Wins Arbitration Against Sun Pharmaceuticals
PremiumCompany AnnouncementsCipher Pharmaceuticals Wins Arbitration Against Sun Pharmaceuticals
11M ago
Cipher Pharmaceuticals Mourns the Loss of Esteemed Board Member Harold Wolkin
Premium
Company Announcements
Cipher Pharmaceuticals Mourns the Loss of Esteemed Board Member Harold Wolkin
1y ago
Cipher Pharmaceuticals’ Record Earnings Driven by Natroba
Premium
Company Announcements
Cipher Pharmaceuticals’ Record Earnings Driven by Natroba
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >